Web Stats Provided By Google Analytics

Wednesday, November 27, 2013

NeuroPace Gets FDA Premarket Approval for the RNS System to Treat Medically Refractory Epilepsy

NeuroPace, Inc. announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.

http://www.hispanicbusiness.com/2013/11/26/neuropace_gets_fda_premarket_approval_for.htm

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts